1-ethyl-3-fluoro-5-[(5S)-4-(4-chlorophenyl)-4-(2-fluoro-4-pyridyl)-5-methyl-2-imidazolin-2-yl]-2-pyridone | 677762-45-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-ethyl-3-fluoro-5-[(5S)-4-(4-chlorophenyl)-4-(2-fluoro-4-pyridyl)-5-methyl-2-imidazolin-2-yl]-2-pyridone
• 英文别名: 5-[(4S)-5-(4-chlorophenyl)-5-(2-fluoropyridin-4-yl)-4-methyl-1,4-dihydroimidazol-2-yl]-1-ethyl-3-fluoropyridin-2-one
• CAS: 677762-45-7
• 化学式: C₂₂H₁₉ClF₂N₄O
• 分子量: 428.869
• InChiKey: UCXOBFWKSRAPNH-JHAYDQECSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  30
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  57.6
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• N-substituted-2-oxodihydropyridine derivatives
  申请人：——

  公开号：US20040072874A1

  公开（公告）日：2004-04-15

  A compound of the formula (I): 1 (wherein Ar 1 and Ar 2 are independently aryl or heteroaryl, any of which is optionally substituted by a substituent selected from the group consisting of cyano, halogen, nitro, lower alkyl, halo-lower alkyl, hydroxy-lower alkyl, cyclo-lower alkyl, cyclo (lower alkyl)-lower alkyl, lower alkenyl, lower alkylamino, di-lower alkylamino, lower alkanoylamino, lower alkylsulfonylamino, arylsulfonylamino, hydroxy, lower alkoxy, halo-lower alkoxy, aryloxy, heteroaryloxy, lower alkylthio, carboxyl, formyl, lower alkanoyl, lower alkoxycarbonyl, carbamoyl, lower alkylcarbamoyl, di-lower alkylcarbamoyl, lower alkylsulfonyl, arylsulfonyl, aryl and heteroaryl; R 1 and R 2 are independently lower alkyl, cyclo-lower alkyl, cyclo(lower alkyl)-lower alkyl or lower alkoxy, any of which is optionally substituted by a substituent selected from the group consisting of halogen, lower alkylamino, di-lower alkylamino, lower alkanoylamino, hydroxy, lower alkoxy, formyl, lower alkoxycarbonyl, lower alkylcarbamoyl and di-lower alkylcarbamoyl; R 3 , R 4 and R 5 are independently hydrogen, cyano, halogen or hydroxy, or lower alkyl, lower alkoxy or lower alkylthio, the last three groups being optionally substituted by a substituent selected from the group consisting of halogen, lower alkylamino, di-lower alkylamino, lower alkanoylamino, hydroxy, lower alkoxy, formyl, lower alkoxycarbonyl, lower alkylcarbamoyl and di-lower alkylcarbamoyl), or a salt or ester thereof is useful as a neuropeptide Y receptor antagonist agent and is also useful as an agent for the treatment of bulimia, obesity or diabetes.

  化合物的结构式(I):1（其中Ar1和Ar2分别独立地为芳基或杂环芳基，任何一个可以选择性地被来自以下组的取代基取代，该组包括氰基、卤素、硝基、较低烷基、卤代较低烷基、羟基较低烷基、环较低烷基、环（较低烷基）-较低烷基、较低烯基、较低烷基氨基、二较低烷基氨基、较低烷酰氨基、较低烷基磺酰氨基、芳基磺酰氨基、羟基、较低烷氧基、卤代较低烷氧基、芳氧基、杂环芳氧基、较低烷硫基、羧基、甲酰基、较低烷酰基、较低烷氧羰基、氨基甲酰基、较低烷基氨基甲酰基、二较低烷基氨基甲酰基、较低烷基磺酰基、芳基磺酰基、芳基和杂环芳基；R1和R2独立地为较低烷基、环较低烷基、环（较低烷基）-较低烷基或较低烷氧基，任何一个可以选择性地被来自以下组的取代基取代，该组包括卤素、较低烷基氨基、二较低烷基氨基、较低烷酰氨基、羟基、较低烷氧基、甲酰基、较低烷氧羰基、较低烷基氨基甲酰基和二较低烷基氨基甲酰基；R3、R4和R5独立地为氢、氰基、卤素或羟基，或较低烷基、较低烷氧基或较低烷硫基，最后三个基可以选择性地被来自以下组的取代基取代，该组包括卤素、较低烷基氨基、二较低烷基氨基、较低烷酰氨基、羟基、较低烷氧基、甲酰基、较低烷氧羰基、较低烷基氨基甲酰基和二较低烷基氨基甲酰基），或其盐或酯是一种神经肽Y受体拮抗剂药物，也是一种治疗厌食症、肥胖症或糖尿病的药物。
• Pyrrolidone carboxamides
  申请人：Isler Markus

  公开号：US20050192292A1

  公开（公告）日：2005-09-01

  Pyrrolidone carboxamides of formula (I) where R 2 =a group of formula (a) or (b), R 5 =phenyl, heteroalkyl, aryloxy, alkoxy, alkanoyl or —NR 6 R 7 and R 1 , X, R 3 , R 4 , R 6 and R 7 have the meanings given in the description and the claims, pharmaceutically applicable acid addition salts with basic compounds of formula (I), pharmaceutically applicable salts of acid compounds of formula (I) with bases, pharmaceutically applicable esters of hydroxy- or carboxy-group containing compounds of formula (I) and hydrates and solvates thereof, inhibit the interaction of neuropeptide Y (NPY) with one of the neuropeptide receptor subtypes (NPY-Y5) and are particularly suitable for the prevention and treatment of arthritis, diabetes and especially eating disorders and obesity. The above can be produced by known methods and converted into a galenic dosage form.

  式 (I) 的吡咯烷酮羧酰胺，其中 R 2 =式 (a) 或 (b) 的基团，R 5 =苯基、杂烷基、芳氧基、烷氧基、烷酰基或-NR 6 R 7 和 R 1 ，X，R 3 , R 4 , R 6 和 R 7 具有在说明书和权利要求书中给出的含义；式(I)碱性化合物的药学上适用的酸加成盐；式(I)酸性化合物与碱的药学上适用的盐；含羟基或羧基的式(I)化合物的药学上适用的酯及其水合物和溶剂、抑制神经肽 Y（NPY）与一种神经肽受体亚型（NPY-Y5）的相互作用，特别适用于预防和治疗关节炎、糖尿病，尤其是进食障碍和肥胖症。上述药物可通过已知方法生产，并转化为半成品剂型。
• N-SUBSTITUTE-2-OXODIHYDROPYRIDINE DERIVATIVES AS NPY ANTAGONISTS
  申请人：BANYU PHARMACEUTICAL CO., LTD.

  公开号：EP1546133A2

  公开（公告）日：2005-06-29
• US6869966B2
  申请人：——

  公开号：US6869966B2

  公开（公告）日：2005-03-22
• US7138525B2
  申请人：——

  公开号：US7138525B2

  公开（公告）日：2006-11-21